Adjuvant Imiquimod Therapy to Reduce Recurrence Rate in Patients After Surgical Therapy of Anal HPV-lesions
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Imiquimod (Primary)
- Indications Condylomata acuminata; Human papillomavirus infections
- Focus Therapeutic Use
- 26 Feb 2018 New source identified and integrated (European Clinical Trials Database record; EudraCT2017-000842-23).
- 14 Dec 2017 Planned primary completion date changed from 31 May 2019 to 31 Dec 2019.
- 14 Dec 2017 Planned initiation date changed from 1 Dec 2017 to 1 Jan 2018.